Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
COAG
OMER
Add up to 3 more stocks
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
-6.93%
$28.47-2.12Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$1.33B
52W Range
$23.00 - $55.42
OMER
Omeros Corporation
-1.69%
$18.58-0.32Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$1.34B
52W Range
$4.06 - $21.24
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 10.80 |
| Forward P/E | N/A | 20.49 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.93 | N/A |
| P/S Ratio | N/A | 35.00 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 324.9% |
| ROE | N/A | N/A |
| ROA | -32.8% | 43.5% |
| ROIC | -38.1% | -32.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 35.85 | 1.95 |
| Quick Ratio | 35.85 | 1.94 |
| Debt/Equity | 0.00 | N/A |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.